 OpGen NASDAQ: OPGN stock is rocketing higher on Tuesday after posting results from its Unyvero urinary tract infections UTI clinical trial. This clinical trial covered Unyvero UTI Panels ability to detect UTIs from clean-catch or catheter-related urine samples. 